Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Breast Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Obesity 1Non-alcoholic Fatty Liver Disease 1

Interventions

Exercise 4semaglutide 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Topiramate 1Tirzepatide 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Resistance Training 1Qsymia 1Phentermine 1Naltrexone 1Liraglutide 1Glucagon-Like Peptide-1 Receptor 1Fluorescence Polarization Immunoassay 1Exercise Test 1Echocardiography 1Docosahexaenoic Acids 1Diethylpropion 1Diet, Plant-Based 1Diet 1Counseling 1Caloric Restriction 1Bupropion 1Blood Specimen Collection 1Biopsy 1Adiposity 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Obesity × Docosahexaenoic Acids × Clear all
NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Ain Shams University

Phase 4 Active not recruiting
200 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡